Akebia Therapeutics
A company developing Hypoxia Inducible Factor therapies to treat kidney diseases and other conditions
All edits
June 4, 2013
On June 4, 2013 Akebia Therapeutics completed their series C funding round with $41 million in funding from Satter Investment Management (lead investor), Nova Holdings (lead investor), Venture Investors, Triathlon Medical Venture Partners, Orchard Venture Partners, Novo Holdings, Novartis Venture Fund, Kearny Venture Partners, Athenian Venture Partners, and AgeChem Venture Fund.
April 26, 2011
On April 26, 2011 Akebia Therapeutics completed their series B funding round with $22 million in funding from Venture Investors (lead investor), Novartis Venture Fund (lead investor), Triathlon Medical Venture Partners, Orchard Venture Partners, Kearny Venture Partners, and Athenian Venture Partners, and AgeChem Venture Partners.
July 8, 2009
On July 28, 2009 Akebia Therapeutics completed their series A funding round with $25 million in funding from Venture Investors (lead investor), Novartis Venture Fund (lead investor), Triathlon Medical Venture Partners, Orchard Venture Partners, Kearny Venture Partners, and Athenian Venture Partners.
On July 28, 2009 Akebia Therapeutics completed their series A funding round with $25 million in funding from Venture Investors (lead investor), Novartis Venture Fund (lead investor), Triathlon Medical Venture Partners, Orchard Venture Partners, Kearny Venture Partners, and Athenian Venture Partners.
On April 26, 2011 Akebia Therapeutics completed their series B funding round with $22 million in funding from Venture Investors (lead investor), Novartis Venture Fund (lead investor), Triathlon Medical Venture Partners, Orchard Venture Partners, Kearny Venture Partners, and Athenian Venture Partners, and AgeChem Venture Partners.
On June 4, 2013 Akebia Therapeutics completed their series C funding round with $41 million in funding from Satter Investment Management (lead investor), Nova Holdings (lead investor), Venture Investors, Triathlon Medical Venture Partners, Orchard Venture Partners, Novo Holdings, Novartis Venture Fund, Kearny Venture Partners, Athenian Venture Partners, and AgeChem Venture Fund.
Find more companies like Akebia Therapeutics
